EP1027430A4 - SERIES OF 64 HUMAN SECRETED PROTEINS - Google Patents

SERIES OF 64 HUMAN SECRETED PROTEINS

Info

Publication number
EP1027430A4
EP1027430A4 EP98934551A EP98934551A EP1027430A4 EP 1027430 A4 EP1027430 A4 EP 1027430A4 EP 98934551 A EP98934551 A EP 98934551A EP 98934551 A EP98934551 A EP 98934551A EP 1027430 A4 EP1027430 A4 EP 1027430A4
Authority
EP
European Patent Office
Prior art keywords
series
secreted proteins
human secreted
human
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98934551A
Other languages
German (de)
French (fr)
Other versions
EP1027430A1 (en
Inventor
Steven M Ruben
Craig A Rosen
Paul E Young
John M Greene
Jian Ni
Ping Feng
Kimberly A Florence
Jing-Shan Hu
Ann M Ferrie
Guo-Liang Yu
Roxanne Duan
Janet Fouad
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Priority to EP03012177A priority Critical patent/EP1346999A3/en
Publication of EP1027430A1 publication Critical patent/EP1027430A1/en
Publication of EP1027430A4 publication Critical patent/EP1027430A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP98934551A 1997-07-16 1998-07-15 SERIES OF 64 HUMAN SECRETED PROTEINS Withdrawn EP1027430A4 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP03012177A EP1346999A3 (en) 1997-07-16 1998-07-15 Human secreted protein

Applications Claiming Priority (41)

Application Number Priority Date Filing Date Title
US5287297P 1997-07-16 1997-07-16
US5266197P 1997-07-16 1997-07-16
US5287397P 1997-07-16 1997-07-16
US5287097P 1997-07-16 1997-07-16
US5287597P 1997-07-16 1997-07-16
US5287497P 1997-07-16 1997-07-16
US5287197P 1997-07-16 1997-07-16
US52871P 1997-07-16
US52873P 1997-07-16
US52870P 1997-07-16
US52661P 1997-07-16
US52872P 1997-07-16
US52875P 1997-07-16
US52874P 1997-07-16
US5344197P 1997-07-22 1997-07-22
US5344297P 1997-07-22 1997-07-22
US5344097P 1997-07-22 1997-07-22
US53441P 1997-07-22
US53440P 1997-07-22
US53442P 1997-07-22
US5636197P 1997-08-18 1997-08-18
US5595297P 1997-08-18 1997-08-18
US5568397P 1997-08-18 1997-08-18
US5635997P 1997-08-18 1997-08-18
US5594697P 1997-08-18 1997-08-18
US5598597P 1997-08-18 1997-08-18
US5572697P 1997-08-18 1997-08-18
US5598997P 1997-08-18 1997-08-18
US5572497P 1997-08-18 1997-08-18
US5572597P 1997-08-18 1997-08-18
US56359P 1997-08-18
US55683P 1997-08-18
US55952P 1997-08-18
US55724P 1997-08-18
US55946P 1997-08-18
US55985P 1997-08-18
US55989P 1997-08-18
US55726P 1997-08-18
US55725P 1997-08-18
US56361P 1997-08-18
PCT/US1998/014613 WO1999003990A1 (en) 1997-07-16 1998-07-15 64 human secreted proteins

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP03012177A Division EP1346999A3 (en) 1997-07-16 1998-07-15 Human secreted protein

Publications (2)

Publication Number Publication Date
EP1027430A1 EP1027430A1 (en) 2000-08-16
EP1027430A4 true EP1027430A4 (en) 2001-09-19

Family

ID=27586422

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98934551A Withdrawn EP1027430A4 (en) 1997-07-16 1998-07-15 SERIES OF 64 HUMAN SECRETED PROTEINS

Country Status (5)

Country Link
EP (1) EP1027430A4 (en)
JP (1) JP2003524366A (en)
AU (1) AU8404598A (en)
CA (1) CA2296815A1 (en)
WO (1) WO1999003990A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7057017B2 (en) 1997-04-16 2006-06-06 Millennium Pharmaceuticals, Inc. Human dickkopf-related protein and nucleic acid molecules and uses therefor
US7446181B2 (en) 1998-01-15 2008-11-04 Millennium Pharmaceuticals, Inc. Antibodies that bind human Dickkopf-1 proteins
US7258973B2 (en) * 1998-08-31 2007-08-21 Mayo Foundation For Medical Education & Research Method for detecting a differentially expressed sequence
US6344541B1 (en) 1998-09-25 2002-02-05 Amgen Inc. DKR polypeptides
WO2000043505A2 (en) * 1999-01-22 2000-07-27 Memorec Medical Molecular Research Cologne Stoffel Gmbh Protease with two aspartate radicals in the catalytically active structure
JP2002540763A (en) * 1999-02-10 2002-12-03 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド 33 human secreted proteins
WO2000065067A2 (en) * 1999-04-23 2000-11-02 University Of Washington Prostate-specific polynucleotides, polypeptides and their methods of use
CA2380549A1 (en) * 1999-08-05 2001-02-15 Incyte Genomics, Inc. Secretory molecules
KR100543857B1 (en) * 1999-09-01 2006-01-23 제넨테크, 인크. Promote or inhibit angiogenesis and cardiovascularization
WO2001023558A2 (en) * 1999-09-28 2001-04-05 Incyte Genomics, Inc. Human secretory molecules
WO2001098483A1 (en) * 2000-06-22 2001-12-27 Zoegene Corporation Gene encoding novel protocadherin-like protein
US7927597B2 (en) 2001-04-10 2011-04-19 Agensys, Inc. Methods to inhibit cell growth
US7736654B2 (en) 2001-04-10 2010-06-15 Agensys, Inc. Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
MX2007001221A (en) 2004-08-04 2007-03-23 Amgen Inc Antibodies to dkk-1.
WO2006015497A1 (en) * 2004-08-13 2006-02-16 Val-Chum, S.E.C. Methods of use of a dkk1 protein, immunogenic polypeptides thereof, nucleic acid encoding the dkk1 protein or polypeptides, or ligands thereof for detecting tumors; and for eliciting immune response against tumors

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995024474A1 (en) * 1994-03-10 1995-09-14 Human Genome Sciences, Inc. Bone morphogenic protein-10

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995024474A1 (en) * 1994-03-10 1995-09-14 Human Genome Sciences, Inc. Bone morphogenic protein-10

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL EMBL; 1 July 1998 (1998-07-01), STRAUSBERG: "ox23f12.s1 Soares_fetal_liver_spleen_1NFLS_S1 Homo sapiens cDNA clone", XP002162614 *
DATABASE EMBL EMBL; 17 October 1995 (1995-10-17), DODSWORTH ET AL.: "H.sapiens CpG island DNA genomic Mse1 fragment, clone 183a9, forward read", XP002162609 *
DATABASE EMBL EMBL; 17 October 1995 (1995-10-17), ŸDODSWORTH ET AL.: "H.sapiens CpG island DNA genomic Mse1 fragment, clone 183h4, reverse read", XP002162611 *
DATABASE EMBL EMBL; 18 October 1995 (1995-10-18), DODSWORTH ET AL.: "H.sapiens CpG island DNA genomic Mse1 fragment, clone 170e10, forward read", XP002162610 *
DATABASE EMBL EMBL; 27 May 1996 (1996-05-27), MARRA ET AL.: "mc69c06.r1 Soares mouse embryo NbME13.5 14.5 Mus musculus cDNA clone", XP002162612 *
DATABASE EMBL EMBL; 30 April 1996 (1996-04-30), MARRA ET AL.: "mb25d03.r1 Soares mouse p3NMF19.5 Mus musculus cDNA clone", XP002162613 *
See also references of WO9903990A1 *

Also Published As

Publication number Publication date
EP1027430A1 (en) 2000-08-16
AU8404598A (en) 1999-02-10
CA2296815A1 (en) 1999-01-28
JP2003524366A (en) 2003-08-19
WO1999003990A1 (en) 1999-01-28

Similar Documents

Publication Publication Date Title
EP1039801A4 (en) 207 HUMAN SECRETED PROTEINS
EP1109821A4 (en) 49 HUMAN SECRETED PROTEINS
EP1040117A4 (en) 110 HUMAN SECRETATED PROTEINS
EP1218408A4 (en) 32 HUMAN SECRETED PROTEINS
EP1212343A4 (en) 52 HUMAN SECRETED PROTEINS
EP1181390A4 (en) 27 HUMAN SECRETED PROTEINS
EP1140970A4 (en) 47 HUMAN SECRETED PROTEINS
EP1051426A4 (en) 67 HUMAN SECRETED PROTEINS
EP1064297A4 (en) 95 HUMAN SECRETED PROTEINS
EP1005544A4 (en) 70 HUMAN SECRETED PROTEINS
EP1019091A4 (en) 50 HUMAN SECRETED PROTEINS
EP1212342A4 (en) 18 HUMAN SECRETED PROTEINS
EP1027430A4 (en) SERIES OF 64 HUMAN SECRETED PROTEINS
EP1032838A4 (en) 125 HUMAN SECRETED PROTEINS
EP1192176A4 (en) 49 HUMAN SECRETED PROTEINS
EP1009766A4 (en) 19 HUMAN SECRETED PROTEINS
EP1192278A4 (en) 48 HUMAN SECRETED PROTEINS
EP1165827A4 (en) 45 HUMAN SECRETED PROTEINS
EP1175439A4 (en) 49 HUMAN SECRETED PROTEINS
EP1159284A4 (en) 33 HUMAN SECRETED PROTEINS
EP1189917A4 (en) 48 HUMAN SECRETED PROTEINS
EP1185543A4 (en) 50 HUMAN SECRETED PROTEINS
EP1017707A4 (en) 29 HUMAN SECRETED PROTEINS
EP1003763A4 (en) 83 HUMAN SECRETED PROTEINS
EP1019506A4 (en) 101 HUMAN SECRETED PROTEINS

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000208

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 12N 15/11 A, 7C 12N 15/63 B, 7C 12N 15/00 B, 7C 12N 15/12 B, 7A 61K 38/17 B, 7C 07K 16/00 B, 7C 12P 21/02 B, 7C 12Q 1/68 B, 7G 01N 33/68 B, 7C 07K 14/47 B

A4 Supplementary search report drawn up and despatched

Effective date: 20010803

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20030205

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20030616